共 50 条
Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B
被引:10
|作者:
Van der Walt, Mietha M.
Terre'Blanche, Gisella
Lourens, Anna C. U.
Petzer, Anel
[1
]
Petzer, Jacobus P.
[1
]
机构:
[1] North West Univ, Sch Pharm, Unit Drug Res & Dev, ZA-2520 Potchefstroom, South Africa
基金:
新加坡国家研究基金会;
英国医学研究理事会;
关键词:
Phthalonitrile;
Benzonitrile;
Monoamine oxidase;
MAO;
Inhibition;
Parkinson's disease;
BRAIN;
D O I:
10.1016/j.bmcl.2012.10.070
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
It has recently been reported that nitrile containing compounds frequently act as potent monoamine oxidase B (MAO-B) inhibitors. Modelling studies suggest that this high potency inhibition may rely, at least in part, on polar interactions between nitrile functional groups and polar moieties within the MAO-B substrate cavity. In an attempt to identify potent and selective inhibitors of MAO-B and to contribute to the known structure-activity relationships of MAO inhibition by nitrile containing compounds, the present study examined the MAO inhibitory properties of series of novel sulfanylphthalonitriles and sulfanylbenzonitriles. The results document that the evaluated compounds are potent and selective MAO-B inhibitors with most homologues possessing IC50 values in the nanomolar range. In general, the sulfanylphthalonitriles exhibited higher binding affinities for MAO-B than the corresponding sulfanylbenzonitrile homologues. Among the compounds evaluated, 4-[(4-bromobenzyl)sulfanyl]phthalonitrile is a particularly promising inhibitor since it displayed a high degree of selectivity (8720-fold) for MAO-B over MAO-A, and potent MAO-B inhibition (IC50 = 0.025 mu M). Based on these observations, this structure may serve as a lead for the development of therapies for neurodegenerative disorders such as Parkinson's disease. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:7367 / 7370
页数:4
相关论文